Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7529

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
This text provides information on the cumulative incidence (%) for Atorvastatin and Placebo, with an HR (Hazard Ratio) of 0.64 and a p-value of 0.0005 over a study duration of 2.0 to 3.5 years. The data indicates a significant difference in outcomes between the two treatments.*
FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
This text provides information about the cumulative hazard percentage for placebo and Atorvastatin, along with the hazard ratio (HR) of Atorvastatin compared to placebo. It also mentions the time to the first primary endpoint through four years of follow-up. This data suggests that Atorvastatin may have a significant impact on reducing the risk of the primary endpoint compared to placebo.*
FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
This text presents data comparing the percentage of subjects experiencing events while taking different doses of atorvastatin (10 mg and 80 mg). The hazard ratio for the two doses is provided as well (0.78 with interval 0.69-0.89 and p-value 0.0002). The information also includes the time to the first major cardiovascular endpoint in years (1, 2, 3, 4).*
FDA Label Image

Label Image (Lbl500907529)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.